icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Initial Evaluation of the Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent HCV Following Liver Transplantation
 
 
  Reported by Jules Levin
 
Presented at The Liver Meeting 2013: 64th Annual Meeting of the American Association for the Study of Liver Diseases, November 1-5, 2013, Washington, DC
 
Xavier Forns,1 Robert J. Fontana,2 Dilip Moonka,3 John G. McHutchison,4 William T. Symonds,4 Jill Denning,4 Lindsay McNair,4 Paul Chang,4 Valerie Kivett,4 Mitchell L. Shiffman,5 Michael Charlton6
1Liver Unit, Hospital Clinic, Barcelona, Spain; 2University of Michigan, Ann Arbor, MI; 3Henry Ford Health System, Detroit, MI; 4Gilead Sciences, Inc., Foster City, CA; 5Liver Institute of Virginia, Richmond, VA; 6Mayo Clinic, Rochester, MN

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif